AFM 2026: The New Rules of Financing an Independent Movie
New capital is entering the film business, but that doesn't necessarily mean more money is available for your movie. As AFM approaches, understanding how buyers actually value a film may be the most important financing decision a producer makes.
Every year, producers arrive at the American Film Market looking for money. They have scripts, budgets, cast wish lists, sales estimates, and financing plans that look perfectly reasonable until somebody who actually has to write a check starts asking questions.
This year, they'll arrive to some encouraging headlines. New capital is entering the independent film business, established distributors are expanding their financing relationships, and streaming commitments are helping underpin packages that might otherwise struggle to get made.
On October 26, Lionsgate announced a joint venture with Steven Paul's SP Media (what happened to MCT? whoops), involving a significant capital investment and an arrangement under which SP Media will produce independent features for Lionsgate to distribute. Meanwhile, AFM's November 10–15 edition has made financing a centerpiece of its programming, with sessions devoted to where the money is coming from and the changing mathematics of independent production.
Taken together, these developments suggest an industry finding new ways to put capital to work. But they also expose a distinction that independent producers cannot afford to ignore.
Money entering the film business is not the same thing as money becoming available to independent filmmakers.
A capital-backed distributor, an established producer with a studio relationship, and a first-time filmmaker seeking $2 million in equity are operating in very different financial markets. They may all be making independent films, but they're not selling the same risk.
And increasingly, the question determining whether a movie gets financed isn't simply whether someone believes it can succeed. It's whether enough of the downside can be accounted for before production begins.
The New Money Is Following Distribution, Not Just Production
The Lionsgate–SP Media arrangement is worth examining because of how it combines capital, production, and distribution.
A financier evaluating a standalone film must consider the screenplay, cast, production team, budget, sales estimates, distribution prospects, and the likelihood that the film will ultimately generate enough revenue to repay the investment.
A financier operating alongside an established distributor has access to a different set of resources. Distribution infrastructure, market relationships, release capabilities, and institutional experience can help inform how projects are selected and how their commercial potential is evaluated.
That doesn't eliminate risk. It changes who evaluates it, when they evaluate it, and which parts of the process are already accounted for.
We're seeing another version of this in the larger independent packages being assembled ahead of AFM. Projects involving recognizable actors such as Liam Neeson, Josh Hartnett, and Colin Firth are entering the market with established sales companies and commercial elements that buyers can evaluate before production.
The lesson for smaller independent producers isn't that every movie needs an A-list star. It's that the financing process is moving closer to the distribution decision, and producers who separate those conversations are making their jobs unnecessarily difficult.
Why a Sales Estimate Is Not a Financing Commitment
One of the more persistent problems I encounter is the assumption that a sales estimate represents money a producer can reasonably expect to raise.
It doesn't. A sales estimate is an assessment of potential licensing value, subject to assumptions about cast, genre, budget, delivery, and market conditions. And we’re seeing more large sales agencies defaulting on their own MGs than ever before – not sure if they’re taking bigger risks due to the market or getting greedy, but either way, that makes projections more dubious in the eyes of investors.
Consider a film with a $3 million budget and a sales estimate suggesting $2 million in worldwide licensing potential. A producer might conclude that the project has a relatively manageable $1 million financing gap.
But those estimated sales may take years to materialize. Some territories may not sell at all, others may license for less than expected, and gross licensing receipts will be reduced by commissions, expenses, and potentially financing costs before investors receive their share.
The more useful question is not how much a film might eventually sell for. It's how much of that value can be contracted, financed against, or conservatively relied upon before the money is spent.
That's the distinction between a package that looks commercially promising and one that can actually support a financing structure.
And once you understand that distinction, the next question becomes how to increase the film's value before production without increasing its cost by the same amount.
🔓 PREMIUM SUBSCRIBER CONTENT
The most financeable independent films aren't necessarily the ones with the biggest budgets or most recognizable actors. They're the ones whose producers understand how specific buyers value specific elements—and how to improve those valuations without spending more than the improvement is worth.
That distinction can change how you build your cast, structure your financing, and negotiate distribution before production.
Continue reading to learn:
Where the international money really is: An inside look at how a $1.5 million international sales projection breaks down by territory—and which markets carry the most value.
How to Moneyball your casting: Why a strategically chosen international actor could add more sales value than a far more expensive American name.
The hidden cost of recognizable talent: Why some actors command substantial fees without generating comparable increases in international sales.
The sales estimate trap: Why a film projected to earn millions may still struggle to secure financing—and which revenue financiers can actually rely on.
How to budget backwards: Use realistic sales projections, distribution costs, and recoupment priorities to build a film that has a better chance of returning investors' money.
These are the considerations that can turn a promising independent film into a more commercially defensible investment.
